Pulmonary Diseases due to Mycobacterium Kansasii in Japan

Internal Medicine

Volumn 36, Issue 4, 1997, Pages 240-241

  Yamamoto, Masahiko ^a  

^a Nagoya Medical Examination Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; HUMAN; INCIDENCE; JAPAN; LUNG DISEASE; MICROBIOLOGY; NOTE;

HUMANS; INCIDENCE; JAPAN; LUNG DISEASES; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL;

EID: 0031112266     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.240     Document Type: Article

References (13)

1. Sakatani M. Nontuberculous mycobacteriosis (NTM) in Japan - epidemiologic and clinical study —. Kekkaku 61: 119, 1994 (Abstract in English).
2. Kawabe H, Asano S, Nagano H, Kubota Y. Case report of pleurisy caused by atypical mycobacteria (abstract). Kekkaku 38: 455, 1963 (in Japanese).
3. The Mycobacteriosis Research Group of the Japanese National Chest Hospitals. Studies on the lung diseases due to atypical mycobacteria in Japan (report of the year 1980 of the Mycobacteriosis Research Group of the Japanese National Chest Hospitals). Kekkaku 57:299,1982 (Abstract in English).
4. The Mycobacteriosis Research Group of the Japanese National Chest Hospitals. Studies on the lung diseases due to atypical mycobacteria in Japan (report of the year 1986 of the Mycobacteriosis Research Group of the Japanese National Chest Hospitals). Kekkaku 63:493,1988 (Abstract in English).
5. Buhler VB, Pollak A. Human infection with atypical acid-fast organisms. Report of two cases and pathologic findings. Am J Clin Pathol 23: 363, 1953.
6. Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis 90: 73, 1969.
7. Ahn CH, Lowell JR, Ahn SS, Ahn SI, Hurst AG. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 128: 1048, 1983.
8. Research Committee, British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months treatment with rifampicin and ethambutol. Thorax 49: 442, 1994.
9. Yamada H, Kohyama T, Terashi K, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium kansasii which developed in an immunocompetent young man. Intern Med 36: 298, 1997.
10. Witzig RS, Franzblau SG. Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid. Antimicrob Agents Chemother 37: 1997, 1993.
11. Wallance R.J. Jr, Dunbar D, Brown BA, et al. Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 18: 736, 1994.
12. Nakazono T, Sugita T, Ogata H, et al. Investigation on the treatment of infection due to Mycobacterium kansasii. Kekkaku 69: 587, 1994 (Abstract in English).
13. Slosarek M, Kubin M, Pokorny J. Water as a possible factor of transmission in mycobacterial infections. Cent Eur J Public Health 2: 103, 1994.